Prescription Weight Loss Treatments for Teenagers in the UK: Who Is Eligible?

Childhood and teenage obesity is a complex medical issue.

For some young people, changes to food choices, physical activity and family routines are enough to improve weight and health. For others, particularly those living with significant obesity or weight-related medical problems, lifestyle support alone may not produce sufficient improvement.

In carefully selected cases, prescription weight loss treatment for teenagers may form part of a specialist obesity-management programme.

This does not mean that weight loss injections should be considered a quick solution for teenagers who simply want to lose a few kilograms.

Prescribing weight-management medication to someone under 18 requires a much more careful approach than adult treatment. A specialist service needs to consider:

• age and stage of development;

• growth;

• BMI adjusted for age and sex;

• physical health;

• psychological wellbeing;

• eating behaviour;

• family circumstances;

• previous weight-management support;

• and whether the potential benefits of medication outweigh the risks.

For adolescents aged 12 years and over, certain prescription treatments may be considered where the young person meets specific clinical criteria and treatment takes place under appropriate specialist supervision.

This guide explains who may be eligible for prescription weight loss treatment for teenagers in the UK, how treatments such as Wegovy®▼ work, what the dosing schedule looks like and how a specialist service at 24 HR Pharmacy may support eligible families.

Is Obesity in Teenagers a Medical Condition?

Yes.

Obesity is a chronic health condition rather than simply a matter of appearance or willpower.

In children and teenagers, excess weight may increase the risk of health problems including:

• type 2 diabetes;

• high blood pressure;

• abnormal cholesterol levels;

• obstructive sleep apnoea;

• fatty liver disease;

• joint and orthopaedic problems;

• reduced mobility;

• and psychological difficulties.

The emotional impact can also be significant.

Young people living with obesity may experience:

• bullying;

• stigma;

• poor body image;

• reduced confidence;

• social withdrawal;

• anxiety;

• and low mood.

For these reasons, treatment should focus on improving health, development and quality of life, not achieving a particular body shape.

How Is Obesity Assessed in Teenagers?

Adult BMI cut-offs cannot simply be applied to children and adolescents.

A teenager is still growing, so clinicians interpret BMI using age- and sex-adjusted growth references or centiles.

Assessment may therefore consider:

• height;

• weight;

• BMI centile;

• growth pattern;

• pubertal development;

• previous changes in weight;

• family history;

• and associated medical conditions.

A clinical assessment may also include blood pressure measurements and investigations for conditions such as diabetes, abnormal cholesterol or liver disease where appropriate.

Can Teenagers Get Prescription Weight Loss Medication in the UK?

Potentially, yes.

However, treatment is much more restricted than in adults.

NICE states that weight-management medicines are not generally recommended for children under 12. In younger children, medicine should only be considered in exceptional circumstances involving severe comorbidities and should be initiated and monitored in a specialist paediatric setting.

For young people aged 12 years and over, medicine may be considered in particular circumstances as part of specialist multidisciplinary weight management.

This means medication should sit alongside support with:

• nutrition;

• physical activity;

• behaviour change;

• psychological wellbeing;

• and ongoing monitoring.

It should not be prescribed in isolation.

Which Weight Loss Treatments Can Be Used in Teenagers?

The available options depend on:

• the young person's age;

• licensing;

• BMI and growth;

• existing medical problems;

• clinical guidelines;

• and the judgement of the specialist prescriber.

One important treatment is Wegovy®▼ (semaglutide).

What Is Wegovy®▼?

Wegovy®▼ contains semaglutide, a GLP-1 receptor agonist.

GLP-1 is a naturally occurring hormone involved in appetite and food intake.

Semaglutide acts on GLP-1 receptors and can help:

• reduce hunger;

• increase feelings of fullness;

• reduce food cravings;

• support smaller portion sizes;

• and lower overall calorie intake.

Wegovy is given as a once-weekly injection under the skin.

It is used alongside improvements to diet and physical activity rather than as a replacement for these measures.

Can Wegovy®▼ Be Used From Age 12?

Current UK product information includes Wegovy for adolescents aged 12 years and over in appropriate weight-management circumstances.

The product information specifies that adolescents use the same gradual dose-escalation schedule as adults until a dose of 2.4 mg once weekly or the maximum tolerated dose is reached.

Importantly, weekly doses above 2.4 mg are not recommended for adolescents.

This is different from adults with obesity, for whom newer UK prescribing information may allow a higher 7.2 mg maintenance dose in selected circumstances. That higher adult dose does not apply to teenagers.

Wegovy®▼ Dosing for Teenagers Aged 12+

For adolescents, treatment starts at a low dose and is increased gradually over approximately 16 weeks.

For adolescents, doses above 2.4 mg once weekly are not recommended.

The prescriber may need to delay an increase or review treatment if side effects are difficult to tolerate.

A young person should never increase the dose independently.

Why Does the Wegovy®▼ Dose Start Low?

GLP-1 medicines commonly affect the digestive system.

Starting immediately on the full maintenance dose would increase the likelihood of side effects.

Gradual dose escalation gives the body time to adjust and may reduce the severity of symptoms such as:

• nausea;

• vomiting;

• diarrhoea;

• constipation;

• abdominal discomfort;

• bloating;

• and indigestion.

This is particularly important in adolescents, where hydration, nutrition and healthy growth need careful attention throughout treatment.

How Is Wegovy®▼ Taken?

Wegovy is injected once each week under the skin.

Common injection sites include:

• the abdomen;

• thigh;

• or upper arm.

It can be used at any time of day and with or without food.

The injection site should be varied rather than repeatedly injecting into exactly the same point.

Families should receive clear instructions on how the injection device is used before starting treatment.

What Happens If a Teenager Misses a Wegovy®▼ Dose?

Current UK product information states that if a dose is missed, it may be taken as soon as possible provided it is within five days of the missed dose.

If more than five days have passed, the missed dose should be skipped and the next dose taken on the normal scheduled day.

If several doses have been missed, the clinical team may need to consider whether treatment should restart at a lower dose.

Always follow the instructions supplied by the prescriber and patient leaflet.

Who Might Be Eligible for Wegovy®▼?

Eligibility is not determined simply by a teenager asking for weight loss medication.

A specialist assessment needs to determine whether treatment is justified clinically.

Factors may include:

• age of at least 12 years;

• obesity based on an age- and sex-adjusted BMI assessment;

• weight-related medical complications;

• effect on physical health;

• previous structured attempts at weight management;

• psychological wellbeing;

• suitability for a GLP-1 medicine;

• and willingness of the young person and family to take part in ongoing lifestyle and clinical support.

The final prescribing decision must be individual.

Is Adult BMI Used to Decide Eligibility?

No.

This is an important distinction.

For adults, treatment eligibility frequently uses fixed BMI cut-offs such as 30 kg/m².

For teenagers, BMI needs to be considered against age- and sex-specific growth references.

Using the adult BMI of 30 kg/m² as the only criterion could therefore incorrectly classify a young person's weight.

A specialist clinician should assess growth charts and BMI centiles rather than relying on an adult online BMI calculator alone.

What Health Problems May Be Associated With Teenage Obesity?

An assessment may look for weight-related problems such as:

Type 2 Diabetes

Obesity is a major risk factor for insulin resistance and type 2 diabetes.

Obstructive Sleep Apnoea

Excess tissue around the airway can contribute to repeated pauses in breathing during sleep.

Possible symptoms include:

• loud snoring;

• choking or gasping;

• morning headaches;

• and excessive daytime tiredness.

High Blood Pressure

Hypertension can develop during adolescence and may continue into adulthood.

Abnormal Cholesterol

Young people with obesity can develop raised cholesterol or triglycerides.

Fatty Liver Disease

Excess fat can accumulate in the liver and contribute to metabolic dysfunction.

Orthopaedic Problems

Additional weight can place pressure on developing joints and bones.

Psychological Difficulties

Weight stigma, bullying and body-image concerns may contribute to anxiety, low mood and social withdrawal.

A good weight-management service considers all of these areas rather than concentrating solely on the number on the scales.

How Effective Is Wegovy®▼ in Teenagers?

Wegovy has been studied in adolescents with obesity in the STEP TEENS clinical trial.

The trial involved young people aged 12 to under 18 who received either semaglutide or placebo alongside support with a reduced-calorie diet and increased physical activity.

The UK prescribing information reports a clinically meaningful improvement in BMI with semaglutide at 68 weeks, with substantially more participants achieving meaningful levels of weight loss than those receiving placebo.

Clinical-trial results should not be interpreted as a guarantee.

Individual outcomes vary according to factors such as:

• starting BMI;

• adherence;

• diet;

• activity levels;

• treatment tolerance;

• medical conditions;

• and individual biological response.

Does Medication Replace Healthy Eating and Exercise?

No.

Medication should form part of a wraparound weight-management programme.

NICE specifically highlights the importance of wraparound care alongside medicines for weight management. This includes information and support with diet, nutrition and physical activity.

For teenagers, this is particularly important because treatment needs to support:

• normal growth;

• adequate nutrition;

• bone health;

• muscle development;

• psychological wellbeing;

• and sustainable habits into adulthood.

The goal should not be extreme calorie restriction.

Why a Family-Based Approach Matters

Teenagers usually do not control every part of their food environment.

Parents and carers often influence:

• grocery shopping;

• meal preparation;

• portion sizes;

• eating-out habits;

• availability of snacks;

• transport;

• and opportunities for exercise.

Making one young person eat completely differently from the rest of the family may also create feelings of shame or isolation.

Where possible, healthy changes should therefore involve the household.

Examples might include:

• eating more balanced family meals;

• keeping healthier foods readily available;

• reducing sugary drinks;

• cooking more meals at home;

• planning regular activity;

• and focusing conversations on health rather than appearance.

Psychological Assessment Is Important

Teenage obesity treatment needs to be handled sensitively.

Before medication is prescribed, clinicians may consider:

• body-image concerns;

• bullying;

• anxiety;

• depression;

• emotional eating;

• binge-eating symptoms;

• disordered eating;

• self-esteem;

• and the young person's own feelings about treatment.

Medication should never be used to reinforce unhealthy pressure to become thinner.

Where an eating disorder or significant mental-health concern is suspected, specialist psychological or medical support may need to take priority.

What Side Effects Can Wegovy®▼ Cause?

Common GLP-1 side effects are mainly gastrointestinal and can include:

• nausea;

• vomiting;

• diarrhoea;

• constipation;

• abdominal discomfort;

• indigestion;

• and reduced appetite.

These symptoms are often most noticeable when starting treatment or increasing the dose.

However, severe or persistent symptoms require clinical review.

Why Nutrition Needs Particular Attention in Teenagers

Reduced appetite is part of how Wegovy supports weight loss.

In a growing adolescent, however, excessively reduced food intake can potentially affect nutritional adequacy.

The clinical team may therefore monitor areas such as:

• protein intake;

• vitamins and minerals;

• hydration;

• growth;

• energy levels;

• and overall dietary quality.

NICE specifically notes the importance of considering micronutrient adequacy in young people receiving weight-management medicines because vitamins and minerals remain essential for growth and development.

The aim is controlled, clinically supervised weight management—not starvation or crash dieting.

When Might Wegovy®▼ Not Be Appropriate?

Not every adolescent with obesity will be suitable for semaglutide.

A prescriber needs to consider contraindications, cautions and individual risks.

Treatment may require particular consideration in someone with:

• certain gastrointestinal conditions;

• previous pancreatitis;

• gallbladder problems;

• diabetes treated with medicines that can cause low blood sugar;

• relevant endocrine disorders;

• significant mental-health concerns;

• an eating disorder;

• or other medicines that could affect treatment.

The full medical history must be reviewed before prescribing.

What About Pregnancy?

Weight-loss medication should not be used during pregnancy.

This is an important part of prescribing for adolescents who could become pregnant.

The clinical consultation should provide age-appropriate, confidential advice about pregnancy risk where relevant.

Semaglutide should also be stopped in advance of a planned pregnancy according to its prescribing information.

Can Teenagers Use Mounjaro?

Mounjaro contains tirzepatide.

Its use and licensing need to be considered separately from Wegovy.

A medicine being highly effective for adults does not automatically mean it is appropriate or licensed for teenagers.

A specialist paediatric weight-management service should only prescribe medicines within the relevant licensing, evidence and clinical governance framework.

Parents should never give a teenager medication prescribed to another family member.

What About Weight Loss Pills?

Again, age matters.

Many oral weight-management medicines and newer weight-loss tablets are developed initially for adults.

A medicine being available from an adult online weight-management service does not mean it can automatically be prescribed to someone aged 12, 14 or 16.

Teenage treatment requires age-specific licensing and a specialist clinical decision.

Can Weight Loss Medication Affect Growth?

This is one reason adolescents require specialist monitoring.

Young people are still developing physically.

Treatment needs to balance weight reduction with:

• adequate nutritional intake;

• normal growth;

• bone development;

• muscle development;

• puberty;

• and overall health.

Height, weight and development may therefore form part of ongoing reviews.

How Long Would a Teenager Stay on Treatment?

There is no universal answer.

Treatment should be reviewed regularly to determine:

• whether it is working;

• how well it is tolerated;

• whether growth and nutrition remain appropriate;

• whether physical health is improving;

• whether psychological wellbeing is being maintained;

• and whether continuing medication remains in the young person's best interests.

Medication should never simply be issued repeatedly without follow-up.

What Happens If Treatment Is Stopped?

Weight-management treatment should include planning for what happens after medication.

Appetite may change again after treatment is withdrawn.

Young people and families therefore need ongoing support with:

• eating habits;

• physical activity;

• maintaining progress;

• managing setbacks;

• and avoiding shame or restrictive dieting.

NICE recommends providing support to help maintain weight loss when weight-management medicines are stopped.

Is Wegovy®▼ Available on the NHS for Teenagers?

This area requires some nuance.

NICE's dedicated technology appraisal of semaglutide for managing overweight and obesity in people aged 12 to 17 was terminated because the manufacturer did not submit the evidence required for NICE to make an NHS recommendation. NICE therefore currently does not make a technology-appraisal recommendation for semaglutide in this age group.

That does not mean the medicine lacks a UK adolescent indication.

It means NHS access and commissioning are separate questions from the medicine's licensing.

Families should therefore check the current local NHS pathway or speak with their GP or specialist service regarding NHS availability.

Why Teenage Weight Management Should Be Specialist-Led

Treating obesity in a young person is fundamentally different from selling an adult weight-loss product online.

A specialist service should be capable of considering:

• paediatric growth;

• nutrition;

• physical health;

• psychological health;

• safeguarding;

• medication monitoring;

• behavioural intervention;

• physical activity;

• and family circumstances.

NICE's recommendations emphasise multidisciplinary expertise when weight-management medicines are used in children and young people.

This higher level of clinical oversight is a safety feature rather than an obstacle.

How 24 HR Pharmacy Can Help

At 24 HR Pharmacy, the proposed specialist weight-management pathway for young people aged 12 years and over should be approached differently from the standard adult weight-loss service.

The existing 24 HR Pharmacy weight-management service is based on clinically guided treatment, with medication matched to a patient's health profile, goals and preferences after clinical assessment.

For adolescents, that assessment needs additional safeguards because treatment is more specialised.

1. Specialist Eligibility Assessment

The first stage should establish whether the young person is potentially eligible for treatment.

Assessment may include:

• age;

• height and weight;

• age- and sex-adjusted BMI;

• growth history;

• existing weight-related medical conditions;

• previous weight-management attempts;

• current medication;

• physical activity;

• eating patterns;

• and psychological wellbeing.

2. Parent or Carer Involvement

Where appropriate, parents or carers are an important part of treatment.

They can support:

• medication administration;

• healthy family meals;

• appointment attendance;

• monitoring side effects;

• and sustainable lifestyle changes.

Clinical teams must also respect appropriate confidentiality and safeguarding requirements for the young person.

3. Clinical Prescriber Review

A suitably qualified clinician reviews the assessment to decide whether medication is appropriate.

Treatment should not be automatically approved based only on BMI.

The prescriber must weigh potential benefits against risks and identify whether another condition or specialist referral requires attention first.

4. Correct, Age-Appropriate Dosing

Where Wegovy®▼ is prescribed to an eligible adolescent, dosing follows the age-appropriate licensed schedule:

• 0.25 mg weekly for weeks 1–4

• 0.5 mg weekly for weeks 5–8

• 1 mg weekly for weeks 9–12

• 1.7 mg weekly for weeks 13–16

• 2.4 mg weekly from week 17, or the maximum tolerated dose

Adolescents should not exceed 2.4 mg weekly.

5. Regular Monitoring

Follow-up should consider more than kilograms lost.

Reviews may examine:

• BMI and growth;

• side effects;

• hydration;

• nutritional intake;

• activity;

• mental wellbeing;

• medicine adherence;

• and relevant health markers.

6. Lifestyle and Family Support

Medication should be accompanied by support for:

• healthy eating;

• age-appropriate portion sizes;

• physical activity;

• sleep;

• behaviour change;

• and sustainable family routines.

This wraparound support is an essential part of responsible weight management for young people.

Frequently Asked Questions

Can a 12-year-old take weight loss medication in the UK?

Certain treatments may be considered from age 12 where they are licensed and clinically appropriate.

Treatment should be specialist-led and based on a full assessment rather than simply an adult BMI threshold.

Can teenagers take Wegovy®▼?

Wegovy can be used in appropriately selected adolescents aged 12 years and over according to current UK product information.

A qualified clinician must assess suitability.

What is the Wegovy®▼ starting dose for teenagers?

The starting dose is 0.25 mg once weekly for the first four weeks.

What is the maximum Wegovy®▼ dose for a teenager?

The adolescent dose should be increased to 2.4 mg once weekly or the maximum tolerated dose.

Doses above 2.4 mg weekly are not recommended in adolescents.

Do teenagers use the same Wegovy®▼ dosing schedule as adults?

They use the same escalation schedule up to 2.4 mg.

However, the newer 7.2 mg adult obesity dose should not be used in adolescents.

Does a teenager need a BMI above 30 to get treatment?

Not necessarily.

Adult BMI thresholds should not simply be applied to teenagers.

A clinician assesses BMI relative to age and sex using paediatric growth references alongside the young person's overall health.

Can a teenager get Mounjaro privately?

This depends on the current licence, age indication and clinical circumstances.

It should not be assumed that a treatment available privately for adults is appropriate for adolescents.

Are weight loss injections safe for teenagers?

Licensed medicines have been studied in relevant patient groups, but all medicines can cause side effects.

For young people, careful screening, dose escalation, nutritional monitoring and ongoing specialist review are particularly important.

Will a teenager still need to change their diet?

Yes.

Medication should be combined with nutrition, physical activity and behavioural support.

Extreme or highly restrictive dieting should be avoided because young people still require adequate nutrition for growth and development.

Can a parent order Wegovy®▼ for their teenager?

Medication should only be supplied after an appropriate specialist clinical assessment of the young person.

A parent's request alone does not establish eligibility.

Final Thoughts

Prescription weight loss treatment can be appropriate for some teenagers living with obesity, but it requires substantially more clinical oversight than adult weight-management treatment.

For young people aged 12 years and over, Wegovy®▼ may be considered where the adolescent meets the relevant clinical criteria and a specialist prescriber determines that treatment is appropriate.

The correct adolescent Wegovy dosing schedule is:

• 0.25 mg once weekly for weeks 1–4

• 0.5 mg once weekly for weeks 5–8

• 1 mg once weekly for weeks 9–12

• 1.7 mg once weekly for weeks 13–16

• 2.4 mg once weekly from week 17, or the maximum tolerated dose

Unlike selected adults with obesity, adolescents should not receive weekly Wegovy doses above 2.4 mg.

Medication should always form part of a broader programme that supports nutrition, physical activity, psychological health and healthy development.

Through a specialist adolescent obesity pathway, 24 HR Pharmacy can help families understand whether treatment may be appropriate, arrange careful clinical assessment and provide ongoing monitoring where medication is prescribed.

The aim is not rapid cosmetic weight loss.

It is to help young people living with clinically significant obesity improve their health safely, sensitively and sustainably.